Hepatocyte growth factor prevents advanced glycation end products-induced injury and oxidative stress through a PI3K/Akt-dependent pathway in human endothelial cells
- 4 November 2009
- journal article
- research article
- Published by Elsevier BV in Life Sciences
- Vol. 85 (19-20), 670-677
- https://doi.org/10.1016/j.lfs.2009.09.006
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Advanced glycation end products induce apoptosis in fibroblasts through activation of ROS, MAP kinases, and the FOXO1 transcription factorAmerican Journal of Physiology-Cell Physiology, 2007
- Pattern of MAP kinases p44/42 and JNK activation by non-lethal doses of tributyltin in human natural killer cellsArchives of Toxicology, 2006
- A Novel Function of Plasminogen Activator Inhibitor-1 in Modulation of the AKT Pathway in Wild-type and Plasminogen Activator Inhibitor-1-deficient Endothelial CellsPublished by Elsevier BV ,2006
- Advanced glycation endproducts—role in pathology of diabetic complicationsDiabetes Research and Clinical Practice, 2005
- Point of NO Return for Nitrergic Nerves in Diabetes: A New Insight into Diabetic ComplicationsCurrent Pharmaceutical Design, 2004
- Bcl2 retards G1/S cell cycle transition by regulating intracellular ROSBlood, 2003
- The chemopreventive agent N-(4-hydroxyphenyl)retinamide induces apoptosis through a mitochondrial pathway regulated by proteins from the Bcl-2 familyOncogene, 2003
- Advanced glycation end-products induce apoptosis of bovine retinal pericytes in culture: involvement of diacylglycerol/ceramide production and oxidative stress inductionFree Radical Biology & Medicine, 2002
- Hepatocyte Growth Factor, but Not Insulin-Like Growth Factor I, Protects Podocytes against Cyclosporin A-Induced ApoptosisThe American Journal of Pathology, 2001
- AGEs and their interaction with AGE-receptors in vascular disease and diabetes mellitus. I. The AGE conceptCardiovascular Research, 1998